Central Laboratory

Infectious Diseases

RELY Mono

Rely Mono Rapid Test

Rely-Mononucleosis-Rapid-Test

Specifications

Enhanced sensitivity: 98%
Specificity: >99%
Shelf life of 18 months
Storage: 2 – 30 °C (36 – 86 °F)

RELY Mono detects Infectious Mononucleosis quickly and reliably.

Rely® Mono Rapid Test provides a simple, fast and cost-effective test for Infectious Mononucleosis - sometimes referred to as Mono or glandular fever. Early detection of Infectious Mononucleosis helps reduce the risk of infecting others, minimises the use of unnecessary antibiotics and improves patient care.

Symptoms of Infectious Mononucleosis include fever, sore throat and swollen lymph glands and mimic other serious infections that need different and urgent treatment.

RELY Mono qualitatively detects the presence of mononucleosis in whole blood, serum or plasma specimens.

It is both reliable and accurate, provides results within five minutes and has been CLIA waived for use with whole blood.

By coupling lateral flow technology to the serological test for Mono, RELY Mono provides a convenient two-step point-of-care diagnostic test for the virus.

Convenient room temperature or refrigerated storage and extended dating help manage inventory during seasonal shifts in testing.

Downloads

RELY Mono Product Sheet

Please note this product is FDA approved for sale in the USA only. This product is not CE marked.

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

New R&D facility in Head Office

Special Projects Laboratory opened in EKF’s Cardiff HQ to develop new applications in non-core markets and support other global diagnostics R&D facilities

Medica is the world’s largest medical trade fair. For more than 40 years it has been firmly established on every professional's calendar attracting over 40,000 delegates and over 5,000 exhibitors from 70 countries in 17 halls.

EKF to highlight Lucica® Glycated Albumin-L assay for diabetes patient monitoring at AACC 2019

EKF announces the availability of a liquid, enzymatic test for glycated albumin (GA) that was recently FDA cleared for sales in the U.S. GA, used for intermediate term monitoring of glycemic control in diabetes patients, will be showcased at the 2019 AACC.

EKF at InterLab - Algiers, Algeria 2019

The third edition of the exhibition will be held on 25-27 September 2019 at the Palais des Expositions, SAFEX, Algiers, Algeria.

EKF Quo-Test supports improved medical management of diabetic retinopathy patients

Quo-Test^® HbA1c analyzer is successfully supporting improved medical management of patients with sight-threatening diabetic retinopathy (STDR).

Product showcase

Copyright © 2019 | Powered by Intergage

Quick links

News and Events

Anemia and Hemoglobin testing

Diabetes and HbA1c testing

Support

Social media

ekf orange

Please note: Not all products are available in all countries. Please check availability.

Privacy | Terms & Conditions | Terms of Sale | UK Modern Slavery Act